CDKN1A and prostate carcinoma: Another study showed that ginsenoside Rh2 inhibited the proliferation of prostate cancer cells in a dose-dependent manner, and no CDKN1A cell cycle inhibitor was observed in the increased protein of ginsenoside Rh2.